Bone replacement material on the basis of carbonate and alkali containing calciumphosphate apatites

Claim 2

An agent for filling bone defects, for building up bone, for forming bone-contact layers on the replacements of bones and roots of teeth and for making independent smaller bone replacement parts or implant articles, comprising a calcium phosphate apatite having carbonate and alkali portions, all ions being definedly integrated in the crystal lattice, of the following formula: Ca.sub.10-a-b-x Me.sup.II.sub.a Me.sup.I.sub.b (PO.sub.4).sub.6-x (CO.sub.3).sub.x (OH).sub.2-b-x (H.sub.2 O).sub.w wherein Me I is a singly charged metal ion, Me II is a doubly charged metal ion, a represents the number of double charged metal ions with the exception of Ca and is a value from 0 to 1.0, b represents the number of singly charged metal ions and is a value from 0.05 to 1.2, x represents the number of carbonate ions and is a value from 0.02 to 1.2, the sum b+x being a maximum of 2.0, and w represents the number of water molecules integrated in the crystal lattice and is a value from 0 to b+x wherein at least a portion of the Me I ions are alkali ions and the CO 3 ions are positioned at the PO 4 positions within the apatite lattice.

Claim 3

An agent according to claim 1, further comprising at least one compound selected from the group consisting of conventional physiologically acceptable additives and diluents of bone replacement materials.

Claim 4

An agent according to claim 2, comprising at least one compound selected from the group consisting of organic binders, inorganic binders, physiological salt solutions, medicaments and hormones as physiologically acceptable additives.

Claim 5

An agent according to claim 1, containing 1 to 100% by weight of calcium phosphate apatite of the formula.

Claim 6

The agent according to claim 1, wherein, in the calcium phosphate apatite of formula I, a portion of the hydroxy ions is exchanged for halide ions and/or a portion of the Ca 2+ ions and OH - ions is exchanged for singly charged metal ions and/or a portion of the Ca 2+ ions is exchanged for doubly charged metal ions.

Claim 7

A process for filling bone and tooth defects, for building up bone, for providing bone-contact layers, for bone replacement, or for tooth-root replacement comprising bringing into contact the affected region of bone or tooth with a material containing a calcium phosphate apatite having alkali and carbonate portions, in which all ions are definedly integrated in the crystal lattice, of the following formula: Ca.sub.10-a-b-x Me.sup.II.sub.a Me.sup.I.sub.b (PO.sub.4).sub.6-x (CO.sub.3).sub.x (OH).sub.2-b-x (H.sub.2 O).sub.w wherein Me I is a singly charged metal ion, Mw II is a doubly charged metal ion, a represents the number of doubly charged metal ions with the exception of Ca and is a value from 0 to 1.0, b represents th number of singly charged metal ions and is a value from 0.05 to 1.2, x represents the number of carbonate ions and is a value from 0.2 to 1.2, the sum b+x being a maximum of 2.0, and w represents the number of water molecules integrated in the crystal lattice and is a value from 0 to b+x, wherein at least a portion of the Me I ions are alkali ions and the CO 3 ions are positioned at the PO 4 positions within the apatite lattice.

Claim 8

A process for filling bone and tooth defects, for building up bone, for providing bone-contact layers, for bone replacement, or for tooth-root replacement comprising bringing into contact the affected region of bone or tooth with a material containing a calcium phosphate apatite having alkali and carbonate portions, in which all ions are definedly integrated in the crystal lattice, of the following formula: Ca.sub.10-a-b-x Me.sup.II.sub.a Me.sup.I.sub.b (PO.sub.4).sub.6-x (CO.sub.3).sub.x (OH).sub.2-b-x (H.sub.2 O).sub.w wherein Me I is a singly charged metal ion, Mw II is a doubly charged metal ion, a represents the number of doubly charged metal ions with the exception of Ca and is a value from 0 to 1.0, b represents th number of singly charged metal ions and is a value from 0.05 to 1.2, x represents the number of carbonate ions and is a value from 0.2 to 1.2, the sum b+x being a maximum of 2.0, and w represents the number of water molecules integrated in the crystal lattice and is a value from 0 to b+x, wherein at least a portion of the Me I ions are alkali ions and the CO 3 ions are positioned at the PO 4 positions within the apatite lattice.

Claim 9

The process according to claim 6, wherein, in the calcium phosphate apatite of formula I, a portion of the hydroxy ions is exchanged for halide ions, and/or a portion of the Ca 2+ ions and OH - ions is exchanged for singly charged metal ions and/or a portion of the Ca 2+ ions is exchanged for doubly charged metal ions.

Claim 10

An implant article containing calcium phosphate apatite having alkali and carbonate portions, all ions being definedly integrated in the crystal lattice, wherein the apatite has the formula: Ca.sub.10-a-b-x Me.sup.II.sub.a Me.sup.I.sub.b (PO.sub.4).sub.6-x (CO.sub.3).sub.x (OH).sub.2-b-x (H.sub.2 O).sub.w wherein Me I is a singly charged metal ion, Me II is a doubly charged metal ion, a represents the number of doubly charged metal ions with the exception of Ca and is a value from 0 to 1.0, b represents the number of singly charged metal ions and is a value from 0.05 to 1.2, x represents the number of carbonate ions and is a value from 0.2 to 1.2, the sum b+x being a maximum of 2.0, and w represents the number of water molecules integrated in the crystal lattice and is a value from 0 to b+x, wherein at least a portion of the Me I ions are alkali ions and the CO 3 ions are positioned at the PO 4 positions within the apatite lattice.

Claim 11

An implant article containing calcium phosphate apatite having alkali and carbonate portions, all ions being definedly integrated in the crystal lattice, wherein the apatite has the formula: Ca.sub.10-a-b-x Me.sup.II.sub.a Me.sup.I.sub.b (PO.sub.4).sub.6-x (CO.sub.3).sub.x (OH).sub.2-b-x (H.sub.2 O).sub.w wherein Me I is a singly charged metal ion, Me II is a doubly charged metal ion, a represents the number of doubly charged metal ions with the exception of Ca and is a value from 0 to 1.0, b represents the number of singly charged metal ions and is a value from 0.05 to 1.2, x represents the number of carbonate ions and is a value from 0.2 to 1.2, the sum b+x being a maximum of 2.0, and w represents the number of water molecules integrated in the crystal lattice and is a value from 0 to b+x, wherein at least a portion of the Me I ions are alkali ions and the CO 3 ions are positioned at the PO 4 positions within the apatite lattice.

Claim 12

The implant article according to claim 8, wherein, in the calcium phosphate apatite of formula I, a portion of the hydroxy ions is exchanged for halide ions, and/or a portion of the Ca 2+ ions and OH - is exchanged for singly charged metal ions and/or a portion of the Ca 2+ ions is exchanged for doubly charged metal ions.

Claim 13

An agent according to claim 2, containing 1 to 100% by weight of calcium phosphate apatite having carbonate and alkali portions according to the formula.

Claim 14

An agent according to claim 3, containing 1 to 100% by weight of calcium phosphate apatite having carbonate and alkali portions according to the formula.

Claim 15

An agent according to claim 2, wherein, in the calcium phosphate apatite of the formula, a portion of the hydroxy ions is exchanged for halide ions, and/or a portion of the Ca 2+ ions and OH ions is exchanged for singly charged metal ions and/or a portion of the Ca 2+ ions is exchanged for doubly charged metal ions.

Claim 16

An agent according to claim 3, wherein, in the calcium phosphate apatite of the formula, a portion of the hydroxy ions is exchanged for halide ions and/or a portion of the Ca 2+ ions and OH ions is exchanged for singly charged metal ions and/or a portion of the Ca 2+ ions is exchanged for doubly charged metal ions.

Claim 17

An agent according to claim 4, wherein, in the calcium phosphate apatite of the formula, a portion of the hydroxy ions is exchanged for halide ions, and/or a portion of the Ca 2+ ions and OH ions is exchanged for singly charged metal ions and/or a portion of the Ca 2+ ions is exchanged for doubly charged metal ions.

Claim 18

An agent according to claim 1, wherein all of said Me I are alkali ions.

Claim 19

An agent according to claim 1, wherein Me I is Na 30 , K 30 , Ag + , the combination Ca 2+ +OH or combinations thereof.

Claim 20

An agent according to claim 1, wherein Me II is Mg 2+ , Pb 2+ , Sr 2+ , Cd 2+ , Mn 2+ , Ca 2+ or combinations thereof.

Claim 21

An agent according to claim 1, wherein Me I is Na 30 .

Claim 22

An agent according to claim 1, wherein at least a portion of said Me I ions are K + ions.

Claim 23

An agent according to claim 1, wherein F ions are incorporated into the apatite lattice at the OH positions.

Claim 24

An agent according to claim 2, wherein said agent comprises about 30-80 weight percent of said calcium phosphate apatite and about 20-70 weight percent of at least one compound of said conventional physiologically acceptable additives.

Claim 25

An implant article according to claim 8, wherein said implant article consists entirely of said calcium phosphate apatite.

Claim 26

An implant article according to claim 8, wherein said article is an endoprosthesis which is at least partially coated with said calcium phosphate apatite.

Claim 27

An implant article according to claim 8, wherein said article comprises a hydroxyapatite core with an external coating of said calcium phosphate apatite.

Claim 28

An implant article according to claim 8, wherein said article is an implant of biocompatible material with a uniform outer coating of said calcium phosphate apatite.